Empirical Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.99M Buy
16,535
+4,054
+32% +$468K 0.52% 34
2025
Q4
$1.02M Sell
12,481
-222
-2% -$20.8K 0.29% 92
2025
Q3
$834K Buy
12,703
+898
+8% +$74K 0.23% 133
2025
Q2
$934K Buy
11,805
+1,857
+19% +$148K 0.29% 94
2025
Q1
$893K Sell
9,948
-121,971
-92% -$11.4M 0.3% 88
2024
Q4
$451K Buy
131,919
+106,038
+410% +$10.9M 0.15% 175
2024
Q3
$493K Buy
25,881
+558
+2% +$66.3K 0.18% 168
2024
Q2
$467K Buy
25,323
+23,592
+1,363% +$3.04M 0.18% 171
2024
Q1
$228K Buy
+1,731
New +$213K 0.11% 242

Other funds holding MRK

Empirical Asset Management's MRK Position: Q1 2026 in Review

Empirical Asset Management increased its Merck (MRK) stake by 32% in Q1 2026, buying an estimated $468K and bringing the position to 16,535 shares worth $1.99M. The position accounts for 0.52% of the portfolio, ranked #34.

Empirical Asset Management first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Empirical Asset Management held 16,535 shares of Merck worth $1.99M as of Q1 2026.
  • Empirical Asset Management bought 4,054 Merck shares in Q1 2026, an estimated $468K.
  • Merck made up 0.52% of Empirical Asset Management's portfolio in Q1 2026, its #34 holding.
  • Empirical Asset Management first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Empirical Asset Management's 13F filing for Q1 2026, filed 11 May 2026.